Supplementary Figure 2 from GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 2. Representative cell cycle histograms from MCF-7 and NCIH929 cells treated with 1 μM of GSK1838705A for 48 h.
Authors: Peter Sabbatini, Susan Korenchuk, Jason L. Rowand, Arthur Groy, Qi Liu, Dominic Leperi, Charity Atkins, Melissa Dumble, Jingsong Yang, Kelly Anderson, Ryan G. Kruger, Richard R. Gontarek, Kenneth R. Maksimchuk, Sapna Suravajjala, Russell R. Lapierre, J. Brad Shotwell, Joseph W. Wilson, Stanley D. Chamberlain, Sridhar K. Rabindran, Rakesh Kumar
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361961663
